新闻/Reuters/Gilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboGilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% Placebo阅读全文在TradingView，您可以无限访问来自Reuters和所有其他新闻来源的文章。继续阅读
